S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
5 Hypergrowth Stocks to Buy Now (Ad)pixel
'War of the states': EV, chip makers lavished with subsidies
Gas prices increase in NJ, around nation amid higher demand
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Lanterns and crescents: more retailers court Ramadan buyers
Shipbuilder Austal executives accused of inflating earnings
5 Hypergrowth Stocks to Buy Now (Ad)pixel
No more room for vroom? Paris votes on banishing e-scooters
NASDAQ:KIDS

OrthoPediatrics - KIDS Stock Forecast, Price & News

$44.29
+0.56 (+1.28%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$42.26
$45.07
50-Day Range
$39.69
$49.77
52-Week Range
$35.67
$60.75
Volume
163,089 shs
Average Volume
124,316 shs
Market Capitalization
$1.02 billion
P/E Ratio
1,476.83
Dividend Yield
N/A
Price Target
$55.17

OrthoPediatrics MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
24.6% Upside
$55.17 Price Target
Short Interest
Bearish
7.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.20
Upright™ Environmental Score
News Sentiment
0.31mentions of OrthoPediatrics in the last 14 days
Based on 2 Articles This Week
Insider Trading
Selling Shares
$1.12 M Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.95) to ($0.80) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.96 out of 5 stars

Medical Sector

551st out of 996 stocks

Surgical & Medical Instruments Industry

57th out of 104 stocks


KIDS stock logo

About OrthoPediatrics (NASDAQ:KIDS) Stock

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. It offers products relating to trauma and deformity, scoliosis, and sports medicine and other procedures. The company was founded by Erin Springer Yount and Nick A. Deeter in August 2006 and is headquartered in Warsaw, IN.

Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Stock News Headlines

Analysts Set OrthoPediatrics Corp. (NASDAQ:KIDS) PT at $55.17
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
Bear market expert makes new prediction
Nobody believed Larry Benedict's prediction in February 2020. The DOW plunged 3.5%, and he told CNBC, "It seems like there's much more to come." Within a month, the market plummeted 34%. Then, nobody believed Larry at the start of last year, either. He predicted that "all the indexes will be negative for the year," with the Nasdaq leading the way. Once again, he was spot-on.
See More Headlines
Receive KIDS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OrthoPediatrics and its competitors with MarketBeat's FREE daily newsletter.

KIDS Company Calendar

Last Earnings
2/28/2023
Today
4/01/2023
Next Earnings (Estimated)
5/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:KIDS
Employees
133
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$55.17
High Stock Price Forecast
$62.00
Low Stock Price Forecast
$50.00
Forecasted Upside/Downside
+24.6%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$1.26 million
Pretax Margin
-3.02%

Debt

Sales & Book Value

Annual Sales
$122.29 million
Book Value
$16.54 per share

Miscellaneous

Free Float
16,210,000
Market Cap
$1.02 billion
Optionable
Not Optionable
Beta
0.91

Key Executives

  • David R. Bailey
    President, Chief Executive Officer & Director
  • Fred L. HiteFred L. Hite
    Director, Chief Operating & Financial Officer
  • Peter F. Armstrong
    Chief Medical Officer
  • Joel Batts
    Senior Vice President-Science & Technology
  • Joseph W. Hauser
    Senior Vice President & General Manager













KIDS Stock - Frequently Asked Questions

Should I buy or sell OrthoPediatrics stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for OrthoPediatrics in the last year. There are currently 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" KIDS shares.
View KIDS analyst ratings
or view top-rated stocks.

What is OrthoPediatrics' stock price forecast for 2023?

5 brokers have issued 12 month price objectives for OrthoPediatrics' shares. Their KIDS share price forecasts range from $50.00 to $62.00. On average, they predict the company's stock price to reach $55.17 in the next year. This suggests a possible upside of 24.6% from the stock's current price.
View analysts price targets for KIDS
or view top-rated stocks among Wall Street analysts.

How have KIDS shares performed in 2023?

OrthoPediatrics' stock was trading at $39.73 at the beginning of the year. Since then, KIDS shares have increased by 11.5% and is now trading at $44.29.
View the best growth stocks for 2023 here
.

When is OrthoPediatrics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 3rd 2023.
View our KIDS earnings forecast
.

How were OrthoPediatrics' earnings last quarter?

OrthoPediatrics Corp. (NASDAQ:KIDS) released its quarterly earnings results on Tuesday, February, 28th. The company reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.10. The company earned $30.99 million during the quarter, compared to analysts' expectations of $31.01 million. OrthoPediatrics had a negative trailing twelve-month return on equity of 5.76% and a net margin of 1.03%.

What ETFs hold OrthoPediatrics' stock?

ETFs with the largest weight of OrthoPediatrics (NASDAQ:KIDS) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE), First Trust NASDAQ BuyWrite Income ETF (FTQI), Principal Healthcare Innovators ETF (BTEC) and iShares Micro-Cap ETF (IWC) and

What guidance has OrthoPediatrics issued on next quarter's earnings?

OrthoPediatrics updated its FY 2023 earnings guidance on Tuesday, February, 28th. The company provided EPS guidance of for the period. The company issued revenue guidance of $146.00 million-$149.00 million, compared to the consensus revenue estimate of $149.57 million.

What is Mark Throdahl's approval rating as OrthoPediatrics' CEO?

15 employees have rated OrthoPediatrics Chief Executive Officer Mark Throdahl on Glassdoor.com. Mark Throdahl has an approval rating of 100% among the company's employees. This puts Mark Throdahl in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of OrthoPediatrics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other OrthoPediatrics investors own include AbbVie (ABBV), Freeport-McMoRan (FCX), Gilead Sciences (GILD), Intel (INTC), Advanced Micro Devices (AMD), CRISPR Therapeutics (CRSP), Cisco Systems (CSCO), Walt Disney (DIS), Enterprise Products Partners (EPD) and NVIDIA (NVDA).

When did OrthoPediatrics IPO?

(KIDS) raised $52 million in an initial public offering on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers.

What is OrthoPediatrics' stock symbol?

OrthoPediatrics trades on the NASDAQ under the ticker symbol "KIDS."

How do I buy shares of OrthoPediatrics?

Shares of KIDS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is OrthoPediatrics' stock price today?

One share of KIDS stock can currently be purchased for approximately $44.29.

How much money does OrthoPediatrics make?

OrthoPediatrics (NASDAQ:KIDS) has a market capitalization of $1.02 billion and generates $122.29 million in revenue each year. The company earns $1.26 million in net income (profit) each year or $0.03 on an earnings per share basis.

How many employees does OrthoPediatrics have?

The company employs 133 workers across the globe.

How can I contact OrthoPediatrics?

OrthoPediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The official website for the company is www.orthopediatrics.com. The company can be reached via phone at (574) 268-6379, via email at tbui@theruthgroup.com, or via fax at 574-269-3692.

This page (NASDAQ:KIDS) was last updated on 4/2/2023 by MarketBeat.com Staff